Palatin Technologies is a clinical stage biopharmaceutical company developing [and receiving FDA approval for] best-in-class and first-in-class medicines based on proprietary peptide and small molecul ...

Derisked platform for Metabolic Therapies, with one major commercial milestone reached.

Rejuvenation Technologies is a precision therapeutics and delivery vehicle biotech launched out of Stanford University, preparing for Series A and clinical trials.

RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene, ...

Scenic Biotech's lead compound (NCE) is adressing lysosomal health and prevention of neurodegeneration.Scenic is developing modifier therapies, a new approach to treating disease. Our lead molecule is ...

Score Pharma is redefining the development of next-generation antibody therapeutics through a proprietary process chemistry that enables rapid, low-risk development of second-generation biosuperiors b ...

Sustained Therapeutics is a clinical stage company developing a drug delivery platform technology initially focused on non-opioid pain medication, but extendable to other APIs including significant on ...

KFD Bio is focusing on development of oral enzymes which is characterized with gastro-tolerant novel drugs. The lead compound TRA16, First-in-disease is designed to effectively degrade oxalate from fo ...

Ladenburg’s investment bank has been a member of the New York Stock Exchange since 1879 and offers a full suite of investment banking and capital markets products and services, including proprietary e ...

Opus8, Inc. is a private investment and advisory firm. Our focus is early stage life sciences, medtech, and digital health companies located in North America.